Intra-Cellular Therapies to Present at the Leerink Partners’ 5th Annual Global Healthcare Conference
NEW YORK, Feb. 01, 2016 (GLOBE NEWSWIRE) – Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (“CNS”) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Leerink Partners’ 5th Annual Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, February 10th, 2016 at 8:50 am EST.
http://ir.intracellulartherapies.com/releasedetail.cfm?ReleaseID=952564
3 Likes
The CBD guys are presenting at the same conference (GW pharma)
LONDON, Feb. 04, 2016 (GLOBE NEWSWIRE) – GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the Leerink Partners 5th Annual Global Healthcare Conference to be held at the Waldorf Astoria Hotel in New York City on Wednesday, 10 February at 11:05 a.m. EST.
3 Likes
Andrey
February 5, 2016, 6:53pm
3
I keep wondering if ITI-007 will treat my negative symptoms. Most probably just another letdown. The etiology of negative symptoms is still too poorly understood. Some say a “lazy” DLPFC (dorso-lateral prefrontal cortex) is to blame but there’s no definitive proof.